HomeCompareSYK vs WAB

SYK vs WAB: Dividend Comparison 2026

SYK yields 1.04% · WAB yields 0.45%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WAB wins by $439.7K in total portfolio value· pulled ahead in Year 4
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
WAB
WAB
● Live price
0.45%
Share price
$237.37
Annual div
$1.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$483.0K
Annual income
$337,751.90
Full WAB calculator →

Portfolio growth — SYK vs WAB

📍 WAB pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKWAB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + WAB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
WAB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
WAB
Annual income on $10K today (after 15% tax)
$37.96/yr
After 10yr DRIP, annual income (after tax)
$287,089.12/yr
At 15% tax rate, WAB beats the other by $280,048.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + WAB for your $10,000?

SYK: 50%WAB: 50%
100% WAB50/50100% SYK
Portfolio after 10yr
$263.2K
Annual income
$173,017.44/yr
Blended yield
65.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
WAB
Analyst Ratings
21
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$277.80
+17.0% upside vs current
Range: $221.00 — $315.00
Altman Z
3.3
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
WAB buys
0
No recent congressional trades found for SYK or WAB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKWAB
Forward yield1.04%0.45%
Annual dividend / share$3.40$1.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%100%
Portfolio after 10y$43.3K$483.0K
Annual income after 10y$8,282.98$337,751.90
Total dividends collected$21.0K$450.4K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$428.67$277.80

Year-by-year: SYK vs WAB ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrWAB PortfolioWAB Income/yrGap
1$10,852$152.43$10,789$89.31+$63.00SYK
2$11,838$226.03$11,725$180.12+$113.00SYK
3$13,004$336.89$12,911$365.85+$93.00SYK
4← crossover$14,420$505.63$14,568$753.04$148.00WAB
5$16,195$766.09$17,176$1,588.17$981.00WAB
6$18,504$1,175.64$21,878$3,499.96$3.4KWAB
7$21,635$1,835.40$31,743$8,332.99$10.1KWAB
8$26,082$2,932.10$56,563$22,598.44$30.5KWAB
9$32,737$4,829.68$135,791$75,268.61$103.1KWAB
10$43,312$8,282.98$483,049$337,751.90$439.7KWAB

SYK vs WAB: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

WABStock

Westinghouse Air Brake Technologies Corporation provides technology-based equipment, systems, and services for the freight rail and passenger transit industries worldwide. It operates through two segments, Freight and Transit. The Freight segment manufactures and services components for new and existing freight cars and locomotives; builds new commuter locomotives; rebuilds freight locomotives; supplies railway electronics, positive train control equipment, signal design, and engineering services; and provides related heat exchange and cooling systems. It serves publicly traded railroads; leasing companies; manufacturers of original equipment, including locomotives and freight cars; and utilities. The Transit segment manufactures and services components for new and existing passenger transit vehicles, such as regional trains, high speed trains, subway cars, light-rail vehicles, and buses; refurbishes subway cars; and provides heating, ventilation, and air conditioning equipment, as well as doors for buses and subways. This segment serves public transit authorities and municipalities, leasing companies, and manufacturers of subway cars and buses. It also provides electronically controlled pneumatic braking products; railway electronics; freight car trucks; draft gears, couplers, and slack adjusters; air compressors and dryers; heat exchangers and cooling products; and track and switch products. In addition, the company offers railway braking equipment and related components; friction products; new switcher locomotives; transit locomotive and car overhaul services; and freight locomotive overhaul, modernizations, and refurbishment services. Further, it provides platform screen doors; pantographs; window assemblies; couplers; accessibility lifts and ramps for buses and subway cars; and traction motors. The company was founded in 1869 and is headquartered in Pittsburgh, Pennsylvania.

Full WAB Calculator →
📬

Get this SYK vs WAB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.